Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,234 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · derivative · entry 8 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,234 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise. F6 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2012 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 4 years. F7 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 5,000 | $30.23 | $151,150.00 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 7 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,232 F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.15 to $30.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 5,000 | $31.05 | $155,250.00 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 6 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,232 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.78 to $31.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 5,000 | $30.15 | $150,750.00 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 5 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,232 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 6,710 | $30.56 | $205,057.60 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 4 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,232 F2 · price: Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 6,172 | $3.67 | $22,651.24 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 3 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 696 | $31.42 | $21,868.32 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 2 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,770 F2 · price: Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 1,234 | $3.67 | $4,528.78 |
DisclosureSEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise. Read SEC document |
| January 21, 2022 Filed Jan 21, 2022 22:04 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
PurchaseCommon Shares | 700 | $28.81 | $20,167.00 |
DisclosureSEC source: 0001209191-22-004460 · doc4.xml · nonDerivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,086 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-070231 · doc4.xml · derivative · entry 2 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,086 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F2 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionCommon Shares | 3,086 | $3.67 | $11,325.62 |
DisclosureSEC source: 0001209191-21-070231 · doc4.xml · nonDerivative · entry 1 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:20 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,057 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-069018 · doc4.xml · derivative · entry 3 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,057 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F3 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:20 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 2,057 | $3.67 | $7,549.19 |
DisclosureSEC source: 0001209191-21-069018 · doc4.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 21:13 UTC |
Von Seggern ChristopherChief Commercial Officer
|
PurchaseCommon Shares | 4,000 | $24.40 | $97,600.00 |
DisclosureSEC source: 0001209191-21-068300 · doc4.xml · nonDerivative · entry 1 Von Seggern Christopher · CIK 0001821192 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 20:40 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 17,557 | $31.33 | $550,060.81 |
DisclosureSEC source: 0001209191-21-064931 · doc4.xml · nonDerivative · entry 1 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,186 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:12 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $16.64 | $0.00 |
DisclosureSEC source: 0001209191-21-053304 · doc4.xml · derivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Shares · 150,000 shares Expires 2031-08-22 F1 · derivative.exercise_date: Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| June 03, 2021 Filed Jun 3, 2021 16:42 UTC |
AULIN SHERRYChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-037692 · doc4.xml · derivative · entry 1 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 01:04 UTC |
GANNON STEVENDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038063 · doc4.xml · derivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 01:07 UTC |
Hayden Michael RDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038067 · doc4.xml · derivative · entry 1 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 3, 2021 21:02 UTC |
AZAB MOHAMMADDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038058 · doc4.xml · derivative · entry 1 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 01:09 UTC |
Machado PatrickDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038070 · doc4.xml · derivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 01:16 UTC |
Svoronos DawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038079 · doc4.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 01:00 UTC |
GAROFALO ELIZABETH A.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038055 · doc4.xml · derivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 3, 2021 20:46 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-037707 · doc4.xml · derivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: 25% on the first anniversary of June 3, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:20 UTC |
PATOU GARYDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001209191-21-038431 · doc4.xml · derivative · entry 4 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires 2031-06-02 F3 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,374 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · derivative · entry 8 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 13,374 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F6 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on March 12, 2011 (the "March 2011 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the March 2011 Vesting Commencement Date over the following 4 years. F5 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,345 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · derivative · entry 7 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 12,345 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F4 · derivative.exercise_date: 25% of the shares subject to the Option vested on the one year anniversary of January 1, 2011 (the "January 2011 Vesting Commencement Date") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the January 2011 Vesting Commencement Date. F5 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 2,912 | $18.81 | $54,774.72 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 6 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,232 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.22 to $19.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 3,155 | $18.81 | $59,345.55 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 5 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,144 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.22 to $19.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 2,192 | $18.91 | $41,450.72 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 4 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,299 F2 · price: Represents the closing price of the Company's common shares on May 27, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 13,374 | $3.85 | $51,489.90 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 3 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 2,024 | $18.91 | $38,273.84 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 2 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,117 F2 · price: Represents the closing price of the Company's common shares on May 27, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:11 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 12,345 | $3.76 | $46,417.20 |
DisclosureSEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,008 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · derivative · entry 9 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 36,008 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F5 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3. F6 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,086 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · derivative · entry 8 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,086 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F5 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3. F6 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
SaleCommon Shares | 8,485 | $18.68 | $158,499.80 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 6 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,653 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.54 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
SaleCommon Shares | 2,579 | $18.69 | $48,201.51 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 5 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,138 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Tax withholdingCommon Shares | 5,911 | $18.88 | $111,599.68 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 4 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,717 F2 · price: Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Exercise / conversionCommon Shares | 36,008 | $3.76 | $135,390.08 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 3 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Tax withholdingCommon Shares | 507 | $18.88 | $9,572.16 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 2 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,620 F2 · price: Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 16:07 UTC |
HOLLER FRANK ADirector
|
Exercise / conversionCommon Shares | 3,086 | $3.76 | $11,603.36 |
DisclosureSEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 1 HOLLER FRANK A · CIK 0000938801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| May 24, 2021 Filed May 26, 2021 16:11 UTC |
PIMSTONE SIMON N.Director · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,633 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001209191-21-035911 · doc4.xml · derivative · entry 3 PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 22,633 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F3 · derivative.exercise_date: 25% of the shares subject to the Option vested on the one year anniversary of January 1, 2011 (the "2011 Vesting Commencement Date") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the 2011 Vesting Commencement Date. F4 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period. Read SEC document |
| May 24, 2021 Filed May 26, 2021 16:11 UTC |
PIMSTONE SIMON N.Director · CEO
|
Tax withholdingCommon Shares | 5,076 | $19.17 | $97,306.92 |
DisclosureSEC source: 0001209191-21-035911 · doc4.xml · nonDerivative · entry 2 PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,743 F2 · price: Represents the closing price of the Company's common shares on May 21, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| May 24, 2021 Filed May 26, 2021 16:11 UTC |
PIMSTONE SIMON N.Director · CEO
|
Exercise / conversionCommon Shares | 22,633 | $3.76 | $85,100.08 |
DisclosureSEC source: 0001209191-21-035911 · doc4.xml · nonDerivative · entry 1 PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:13 UTC |
Hayden Michael RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001209191-21-034396 · doc4.xml · derivative · entry 4 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,500 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date. The original grant date of the option is June 1, 2017. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:13 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Shares | 3,500 | $3.85 | $13,475.00 |
DisclosureSEC source: 0001209191-21-034396 · doc4.xml · nonDerivative · entry 1 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:18 UTC |
TARNOW MICHAEL MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,144 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 6 TARNOW MICHAEL M · CIK 0001263647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,144 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F4 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:18 UTC |
TARNOW MICHAEL MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,028 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 5 TARNOW MICHAEL M · CIK 0001263647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,028 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F4 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:18 UTC |
TARNOW MICHAEL MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,057 | $0.00 Strike: $3.87 | $0.00 |
DisclosureSEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 4 TARNOW MICHAEL M · CIK 0001263647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,057 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F3 · derivative.exercise_date: The shares subject to the option fully vested on July 1, 2014. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:18 UTC |
TARNOW MICHAEL MDirector
|
Exercise / conversionCommon Shares | 5,144 | $3.67 | $18,878.48 |
DisclosureSEC source: 0001209191-21-034400 · doc4.xml · nonDerivative · entry 3 TARNOW MICHAEL M · CIK 0001263647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021. F2 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.